Computerized system and method for safely transfusing blood products

• US 8,005,622 B2
• Filed: 12/21/2004
• Issued: 08/23/2011
• Est. Priority Date: 12/21/2004
• Status: Active Grant

• Current Assignee: Cerner Innovation, Inc. (Oracle Corporation)
• Original Assignee: Cerner Innovation, Inc. (Oracle Corporation)
• Inventors: Fry, Jeffrey D., Hauck, Arthur J., Cross, Lori N.
• Primary Examiner(s): Clow; Lori A
• Application Number:
  US11/018,660
• Publication Number:
  US 20060136137A1
• Time in Patent Office: 2,436 Days
• Field of Search: None
• US Class Current: 702/19
• CPC Class Codes: G16H 20/17 delivered via infusion or injection

Abstract

The present invention relates to a system and method for safely transfusing blood to a patient in a computerized healthcare environment is provided. A blood product to be administered to a patient is identified and the patient is identified. A database containing a plurality of blood compatibility test results is accessed and it is determined whether the database contains a blood compatibility test result for the identified blood product and identified patient. If so, it is determined whether the test result indicates that the identified blood product is compatible for the identified patient.

Claims

1. A computer system for displaying a notification that a blood product unit is safe to administer to a patient at the patient'"'"'s location prior to the patient receiving a blood transfusion, the system comprising:

a first receiving component at one or more remote computers located at a patient location for receiving identification to identify the blood product to be administered to the patient;

a second receiving component at the one or more remote computers located at the patient location for receiving identification to identify the patient;

an accessing component for accessing via a network a blood bank database located separate from the patient location, the blood bank database containing a plurality of pre-determined blood compatibility test results;

a determining component for determining whether the database contains a pre-determined blood compatibility test result by comparing compatibility data for the identified blood product from the first receiving component at the one or more remote computers located at the patient location with compatibility data for the identified patient from the second receiving component at the one or more remote computers located at the patient location to verify that the identified blood product is safe to administer to the identified patient; and

a displaying component for displaying a notification to a user at the patient'"'"'s location at the one or more remote computers prior to transfusion that the identified blood product is safe to administer to the identified patient.

2. The system of claim 1, further comprising:

a notifying component at the one or more remote computers for notifying a healthcare user that the blood product is not safe to administer to the identified patient if the blood product is not compatible for the identified patient.

3. The system of claim 1, wherein the patient is identified by a patient identification number.

4. The system of claim 3, wherein the patient identification number is a bar code on a patient identification bracelet that may be scanned.

5. The system of claim 1, wherein the blood product is identified by a blood product identification number assigned by the blood product supplier.

6. The system of claim 5, wherein the blood product identification number is a bar code on the blood product packaging that may be scanned.

7. The system of claim 1, further comprising:

a second determining component executed by the server for determining whether the pre-determined blood compatibility test result for the patient has expired.

8. The system of claim 7, further comprising:

a notifying component notifying a user of the expiration of the predetermined blood compatibility test result.

9. The system of claim 1, further comprising:

a second accessing component for accessing the database to determine whether the identified blood product has expired.

10. The system of claim 9, further comprising:

a notifying component for notifying a user of the expiration of the blood product.

11. The system of claim 1, further comprising:

a second determining component executed by the server for determining if any other blood products have been tested for the identified patient and are compatible for the identified patient if the database does not contain the predetermined blood compatibility test result for the identified blood product and identified patient.

12. The system of claim 11, further comprising:

a third determining component executed by the server for determining if the identified blood product is a compatible blood type for the identified patient if it is determined that no other blood products have been tested and are compatible for the identified patient.

13. The system of claim 12, further comprising:

a comparing component for comparing the blood type of the identified patient with the blood type of the identified blood product to determine if it safe to be administered to the patient.

14. The system of claim 13, further comprising:

a notifying component for notifying a user of the other compatible blood products if any other blood products have been tested and are compatible for the identified patient.

15. A computer system for safely displaying a notification that a blood product unit is safe to administer to a patient at the patient'"'"'s location prior to the patient receiving a blood transfusion, the system comprising:

at one or more remote computers located at a patient location, means for receiving identification to identify a blood product to be administered to a patient;

at the one or more remote computers located at the patient location, means for receiving identification to identify the patient;

means for accessing via a network a blood bank database located separate from the patient location, the blood bank database containing a plurality of pre-determined blood compatibility test results;

means for determining whether the database contains a pre-determined blood compatibility test result by comparing compatibility data for the identified blood product from the one or more remote computers located at the patient location with compatibility data for the identified patient from the one or more remote computers located at the patient location to verify that the identified blood product is safe to administer to the identified patient; and

means for displaying a notification to a user at the patient'"'"'s location at the one or more remote computers prior to transfusion that the identified blood product is safe to administer to the identified patient.

16. The system of claim 15, further comprising:

means for notifying a healthcare user at the one or more remote computers that the blood product is not safe to administer to the identified patient.

17. The system of claim 15, further comprising:

means for determining whether the pre-determined blood compatibility test result for the identified patient has expired.

18. The system of claim 15, further comprising:

means for accessing the database to determine whether the identified blood product has expired.